Idenix measuring the levels of ultra-sensitive troponin

To address the FDA's concerns, Idenix has EKGs on its patients and is running echocardiograms on them. It also is measuring the levels of ultra-sensitive troponin, a measure of cell injury to pick up cardiomyopathy, and pro-brain natriuretic peptide to look at early heart failure. To date, all the assays that Idenix has looked at have been normal.

Read Full Article

Follow us